EEG alterations in subjects at high familial risk for Alzheimer's disease

Neuropsychobiology

Volumn 48, Issue 3, 2003, Pages 152-159

  Ponomareva, N V ^a   Selesneva, N D ^a   Jarikov, G A ^a  

^a BRAIN RESEARCH INSTITUTE   (Russian Federation)

Author keywords

Aging; Alzheimer's disease; EEG; Genetic predisposition; Hyperventilation

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICAL SYNCHRONIZATION; DELTA RHYTHM; DISEASE COURSE; DISEASE PREDISPOSITION; EEG ABNORMALITY; ELECTROENCEPHALOGRAM; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HUMAN; HYPERVENTILATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SEMICONDUCTOR; THETA RHYTHM;

ADULT; AGED; ALZHEIMER DISEASE; BRAIN; ELECTROENCEPHALOGRAPHY; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; RISK FACTORS;

EID: 0242268012     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073633     Document Type: Article

References (54)

1. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J: Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
2. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov L, Cohen D, Lannfeldt L, Fraser PE, Rommens JM, St George-Hyslop PH: Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-778.
3. Blacker D, Tanzi RE: The genetics of Alzheimer's disease: Current status and future prospects. Arch Neurol 1998;55:294-296.
4. Van Broeckhoven C: Molecular genetics of Alzheimer disease: Identification of genes and gene mutations. Eur Neurol 1995;35:8-19.
5. ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
6. Yamagata K, Urakami K, Ikeda K, Ji Y, Adachi Y, Arai H, Sasaki H, Sato K, Nakashima K: High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease. Dementia 2001;12:57-62.
7. Heston LL: Alzheimer's disease; in King RA, Rotter JI, Motulsky AG (eds): The Genetic Basis of Common Diseases. Oxford, Oxford University Press, 1992, pp 792-800.
8. Graff-Radford NR, Hutton ML, Perez-Tur J, Eckman CB, O'Brien PC, Yonkin LH, Younkin SG: Plasma Aβ level in first-degree relatives of Alzheimer's disease patients; in Coleman D (ed): Neurobiology of Aging. Abstracts of the 6th International Conference on Alzheimer's Disease and Related Disorders. Amsterdam, Elsevier, 1998, pp 160-161.
9. Ponomareva NV, Fokin VF, Selesneva ND, Voskresenskaia NI: Possible neurophysiological markers of genetic predisposition to Alzheimer's disease. Dementia 1998;9:267-273.
10. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AS, Pericak-Vance MA, Mazziotta JC, Small GW: Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000;343:450-456.
11. Soininen H, Partanen J, Laulumaa V, Helkala EL, Laakso M, Reikkinen PJ: Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. Electroencephalogr Clin Neurophysiol 1989;72:290-297.
12. Strijers RL, Scheltens P, Jonkman EJ, de Rijke W, Hooijer C, Jonker C: Diagnosing Alzheimer's disease in community-dwelling elderly: A comparison of EEG and MRI. Dementia 1997;8:198-202.
13. Scarone S, Pieri E, Cattaneo R, Gambini O, Colombo C, Pugnetti L: Neurofunctional assessment of early phases of Alzheimer's disease: A preliminary note on hemispheric EEG characteristics during cognitive tasks. Hum Neurobiol 1988;6:289-293.
14. Ponomareva NV, Fokin VF, Selesneva ND: Brain dysfunction and its correction in the relatives of patients with different forms of Alzheimer's disease. Eur Neuropsychopharmacol 2001;11(suppl 1):11-12.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Forces on Alzheimer's Disease. Neurology 1984;34:933-944.
16. Versavel M, Leonard JP, Herrmann WM: Standard operating procedure for registration and computer-supported evaluation of pharmaco-EEG data. Neuropsychobiology 1995;32: 166-170.
17. Gasser T, Bacher P, Mocks J: Transformations towards the normal distribution of broad band spectral parameters of the EEG. Electroencephalogr Clin Neurophysiol 1982;53:119-124.
18. Brenner RP, Ulrich RF, Spiker DG, Sclabassi RJ, Reynolds CF, Marin RS, Boller F: Computerized EEG spectral analysis in elderly normal, demented and depressed subjects. Electroencephalogr Clin Neurophysiol 1986;64:483-492.
19. Duffy FH, Albert MS, McAnulty G: Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Ann Neurol 1984;16:439-448.
20. Schreiter-Gasser U, Gasser T, Ziegler P: Quantitative EEG analysis in early-onset Alzheimer's disease: Correlations with severity, clinical characteristics, visual EEG and CCT. Electroencephalogr Clin Neurophysiol 1994;90:267-272.
21. Lopes de Silva F: Neural mechanisms underlying brain waves. From neural membranes to networks. Electroencephalogr Clin Neurophysiol 1991;79:81-93.
22. Politoff A, Monson N: Age vs aging in the pathogenesis of senile dementia of the Alzheimer type: Electrophysiological evidence. Dementia 1997;8:18-25.
23. Riekkinen PJ, Buzsaki G, Riekkinen P Jr, Soininen H, Partanen VJ: The cholinergic system and EEG slow waves. Electroencephalogr Clin Neurophysiol 1991;78:89-96.
24. Penttila M, Partenen JV, Soininen H, Riekkinen PJ: EEG finding in senile dementia and normal aging. Acta Neurol Scand 1982;65:59-70.
25. Obrist WD: Electroencephalography in aging and dementia; in Katzman R, Terry RD, Bick KL (eds): Alzheimer's Disease: Senile Dementia and Related Disorders. New York, Raven Press, 1978, pp 227-232.
26. Van der Worp HB, Kraaier V, Wieneke GH, Van Huffelen AC: Quantitative EEG during progressive hypocapnia and hypoxia. Hyper-ventilation-induced EEG changes reconsidered. Electroencephalogr Clin Neurophysiol 1991;79:335-341.
27. Zenkov LR, Ronkin MA: Functional Diagnostics of Nervous Diseases (in Russian). Moscow, Medicine, 1991.
28. Niedermeyer E: Focal and generalized seizure discharges in the electroencephalogram and their response to intravenous diazepam. Int Med Dig 1972;7:49-61.
29. Keller WJ, Largen JW, Burch NR, Maulsby RL: Physiology of the aging brain: Normal and abnormal states; in Johnson HA (ed): Relations between Normal Aging and Disease. New York, Raven Press, 1985, pp 165-190.
30. Davydova IG, Kassil VL, Smirnova KD: Changes in the brain bioelectrical activity and in the ACTH content of the blood plasma during voluntary hyperventilation in malignant neoplasm patients. Bull Eksp Biol Med 1988;105:201-203.
31. Gottfries C-G: Alzheimer's disease. A critical review. Compr Gerontol 1988;2:47-62.
32. Gottfries C-G: Regulation of the hypothalamic-pituitary-adrenal axis during dementia disorders. Ageing in a changing Europe. Abstracts. 3rd Eur Congr Gerontol, Utrecht, 1995.
33. Almeida OFX, Conde GL, Crochemore C, Demeneix BA, Fischer D, Hassan AHS, Meyer M, Holsboer F, Michaelidis TM: Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J 2000;14:779-790.
34. Gibbs EL, Gibbs FA, Lennox WG, Nims LF: Regulation of cerebral carbon dioxide. Arch Neurol Psychiatr 1942;47:879-889.
35. Gotoh F, Meyer JS, Takagi Y: Cerebral effects of hyperventilation in man. Arch Neurol 1965;12:410-423.
36. Jibiki I, Kurokawa K, Matsuda H, Fukushima T, Yamaguchi N, Hisada K: Widespread reduction of regional cerebral blood flow during hyperventilation- induced EEG slowing ('buildup'). Observation from subtraction of brain imaging with single photon emission computed tomography using technetium-99m hexamethyl-propyleneamine oxime. Neuropsychobiology 1992;26:120-124.
37. Bonvallet M, Dell P: Reflections on the mechanisms of action of hyperventilation upon the EEG. Electroencephalogr Clin Neurophysiol 1956;8:170.
38. Sherwin I: Alterations in the nonspecific cortical afference during hyperventilation. Electroencephalogr Clin Neurophysiol 1967;23:532-538.
39. Morgan P, Ward B: Hyperventilation and changes in the electroencephalogram and electroretinogram. Neurology 1970;20:1009-1014.
40. Drake ME: Paroxysmal hyperventilation responses in the adult electroencephalogram. Clin Electroencephalogr 1986;17:61-65.
41. Darrow CW, Green JR, Davis EW, Carol HW: Parasympathetic regulation of high potential in the EEG. J Neurophysiol 1944;7:217-226.
42. LaFerla FM: The Alzheimer's beta-amyloid peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Behav Pharmacol Suppl 1995;6:55.
43. Fokin VF, Ponomareva NV, Orlov ON, Lideman RR, Erin AN: Relations between electricity reactions of the brain and lipid peroxidation in patients with pathological aging (in Russian). Bull Eksp Biol Med 1989;54:682-684.
44. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA: A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease. Proc Natl Acad Sci USA 1994;91:3270-3274.
45. Ghosh SS, Scott M, Herrnstadt C, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD, Davis RE: Mitochondrial dysfunction and Alzheimer's disease; in Fisher A, Hanin I, Yoshida M (eds): Progress in Alzheimer's and Parkinson's Diseases. New York, Plenum Press, 1998, pp 59-66.
46. Pettegrew JW, Klunk WE, Kanal E, Panchalingam K, Kanfer JN, McClure RJ: Alterations of cerebral metabolism in probable Alzheimer's disease. Neurobiol Aging 1994;15:117-132.
47. Sakamoto S, Ishii K, Sasaki M, Hosaka K, Mori T, Matsui M, Hirono N, Mori E: Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J Neurol Sci 2002;200:27-32.
48. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L, et al: Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995;273:942-947.
49. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D: Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N Engl J Med 1996;334:752-758.
50. Bickford RG: Activation procedures and special electrodes; in Klass DW, Daly DD (eds): Current Practice of Clinical Electroencephalography. New York, Raven Press, 1979, pp 269-305.
51. Meier-Ruge WA, Bertoni-Freddari C: Mitochondrial genome lesions in the pathogenesis of sporadic Alzheimer's disease. Gerontology 1999;45:289-297.
52. Balzamo E, Gayan Ramirez G, Jammes Y: Quantitative EEG changes under various conditions of hyperventilation in the sensorimotor cortex of the anaesthetized cat. Electroencephalogr Clin Neurophysiol 1991;78:159-165.
53. Buroiv I, Kaplan A: An electroencephalographic analysis of the anti-ischemic properties of amiridin. Eksp Klein Farmakol 1993;56:4-5.
54. Moore NC, Tucker KA, Jann MW, Hostetler RM, Coburn KL: Flash P2 delay is a probable biological marker of primary degenerative dementia of the Alzheimer type. Clinical neuropharmacology. Proc 18th Congr Coll Int Neuropharmacol, Nice, 1992, vol 15, 291 B.